Just What the Doctor Ordered: Using SAS to Calculate Patient Drug Dose with Electronic Medical Record (EMR) Prescription Data
|
|
- Preston Malone
- 8 years ago
- Views:
Transcription
1 Just What the Doctor Ordered: Using SAS to Calculate Patient Drug Dose with Electronic Medical Record (EMR) Prescription Data Kathy Hardis Fraeman, United BioSource Corporation, Bethesda, MD ABSTRACT Electronic medical records (EMRs) are paperless digital versions of physicians paper charts. EMRs can contain a myriad of health care information including details of physician drug prescriptions and research efforts with EMR data often include determining patient drug treatment patterns and dose modifications. Unfortunately, electronic versions of physician prescriptions are often as varied and undecipherable as their paper counterparts. Elements in EMR drug prescription data include the often unstandardized text name of the drug, and inconsistently used numeric variables indicating the number of pills to be taken at one time, the number of times per day the pills should be taken, number of days the pills should be taken, and dosage amount per pill. Further, dosing instructions are often given as unstandardized Latin abbreviations, such as BID, QD, and PRN. Although there s no right way to analyze such varied EMR drug prescription data, programming tips and techniques with Base SAS are presented that show ways to derive patient drug dose and treatment patterns with EMR data. Examples from a general practice EMR and an outpatient oncology EMR are used to illustrate the tips and techniques. INTRODUCTION Electronic medical records (EMRs) can be described as paperless, digital versions of the patient chart folders found on rows of shelves in physicians offices. EMRs can contain a wide variety of health care information, including medical histories, details of diagnoses and treatments, clinical laboratory test results and treatment responses, and visit scheduling and billing information. Numerous studies have touted the advantages for physicians using EMR systems, as EMRs have the potential to improve the quality of patient care while substantially reducing medical costs. Although EMRs are not yet widely used in a majority of physician offices, their use is increasing. A survey conducted by the CDC s National Center for Health Statistics found that almost one in four physicians reported using either full or partial EMR systems in their office-based practices in 2005, representing a 32% increase since While physicians use EMRs to improve the quality of medical care and efficiency of their practices, scientists and medical researchers see the enormous research potential in de-identified EMR data. Not only do EMR data provide a wealth of information about real-world medical practices, they also include laboratory results and patient treatment response assessments not usually found in insurance claims databases. EMR data further provide important patient demographics not available in insurance claims data, such as patient height and weight, and smoking status and alcohol use. As the saying goes, if you ve seen one EMR, you ve seen one EMR. EMRs are not standardized in terms of either their database structure or content, and there s no single or right way to analyze EMR data for their wide range of research possibilities. Drug prescription data one of the many types of data found in EMRs can be very useful for a variety of research efforts, but these electronic drug prescription data can also be as undecipherable as their paper prescription counterparts. SPECIFIC EMRS The two EMRs discussed in this paper are: a general practice EMR, and an outpatient oncology EMR. All of the patient data in these EMRs are de-identified, as required by the Health Insurance Portability and Accountability Act of 1996 (HIPAA) regulations. GENERAL PRACTICE EMR The general practice EMR is a database containing medical data from a group of over 2,600 general practitioners and over 6 million patients. More than half of the states in the US are represented, and the average length of follow-up for patients is approximately 3 years. This database includes detailed information regarding patient demographics, such as patient height and weight, smoking status, and alcohol use. The general practice EMR 1
2 also includes the results of several hundred different types of laboratory tests, and provides complete information on all drugs for which a prescription is written for patients receiving care from that practice. The general practice EMR contains 17 separate data sets, four of which contain prescription drug information. OUTPATIENT ONCOLOGY EMR The outpatient oncology EMR database includes medical and treatment information for more than 185,000 cancer patients from 18 outpatient oncology provider organizations comprising 71 clinic locations in 15 different states across the United States. The EMR contains descriptions of prescribed chemotherapy treatment regimens, including the number and length of each chemotherapy cycle within the regimen. The EMR also contains physician prescription information for each specific chemotherapy agent included in the regimen, along with prescriptions for supportive care drugs for the side effects of chemotherapy and palliative care for cancer patients. If the chemotherapy agents or supportive care drugs are administered medically at the cancer clinic, usually by injection or infusion, then the EMR records information about the drug administrations at the clinic. The outpatient oncology EMR contains 49 separate data sets, six of which contain drug prescription and drug administration information, although our drug analyses with these EMR data only use three data sets. CONVERTING EMR DATA TO SAS None of the data in either of these two EMRs were originally collected in SAS format at the physician offices or oncology clinics, and these data are not delivered to research clients in SAS format. The original EMR data were collected using other relational database packages, and these relational databases were received for analysis as multiple separate text files. These text files had to be converted into SAS format data sets, with the appropriate variable characteristics, labels, and formats. The EMR data also needed varying degrees of internal standardization, especially for the variables relevant to deriving patient drug dosing and treatment patterns. EMR Programming Tip Converting non-sas EMR data to SAS format Conversion of non-sas EMR data into a SAS data set format can be time-consuming, especially given the large number of data sets, variables, and attached formats found in most EMRs. If non-sas EMR data are delivered with an electronic data dictionary, it s possible to use that data dictionary as part of the data conversion process. The electronic data dictionary can be converted to SAS meta-data, which can then be used to dynamically generate SAS DATA-step programming, such as format, label, and length statements, to be used as part of the data conversion process. For an example of this programming technique, see Fraeman, NESUG DRUG PRESCRIPTION DATA VS. DRUG DISPENSING DATA Electronic medical records contain drug prescription data, rather than the actual drug dispensing information found in medical insurance claims data. EMR prescription data describes how a drug was prescribed for the patient by the physician, but EMR data can t verify if that prescription was actually filled. If the prescription indicates an allowable number of refills, the EMR data won t be able to directly indicate if the patient actually ever refilled the prescription. One advantage of EMR drug prescription data over insurance claims drug dispensing data is that EMRs are able to monitor physician prescriptions for over-the-counter medications. EMR Programming Tip Analytically interpreting EMR prescription data There are no standard rules about how to interpret patient drug use with drug prescription data as opposed to drug dispensing data, other than to be aware of this distinction. It is important to know about the drugs being studied, the medical conditions being treated by these drugs, and the types of treatment patterns that might be expected for these medical conditions. Most importantly, it is very important to look at the actual EMR drug prescription data, paying special attention to the relative timing and dates of each patient s drug prescriptions. Understanding the drugs, diseases, and the actual EMR drug prescription data will help develop study-specific rules on how to interpret the EMR drug prescription data. 2
3 DRUG PRESCRIPTION DATA IN EMRS The data sets, or files, in an EMR that provide information about each patient s drug prescriptions -- and variables contained within each drug prescription data file -- can vary across different EMRs. GENERAL PRACTICE EMR The drug prescription data in the general practice EMR have already undergone some degree of standardization prior to receipt of the data. The prescription drug files and selected variables found in these files from the general practice EMR are described below: EMR File Description Selected Variables General Practice EMR Drug Reference File One observation for each drug Patient Medication File One observation for each patient medication Patient Prescription File One observation for each patient prescription Sig File One observation for each set of medication instructions Medication Key Unique drug identifier Names of drug product and generic Numeric drug strength and units of measure Drug Generic Product Index (GPI) code National Drug Council (NDC) code Medication Categories Medication Key Unique drug identifier Sig Key Unique key for medication instructions Drug start and stop dates Drug active flag Drug stop reason Medication Key Unique drug identifier Prescription Key Unique prescription identifier Prescription Date Number of refills Sig Key Unique key for medication instructions Medication frequency, dose, route EMR Programming Tip Efficiently using the Drug Reference File A Drug Reference File in an EMR will have a unique drug key variable associated with each drug, and will have more detailed drug information, such as complete drug name, drug strength, formulation, and route of administration. Each entry in the EMR Patient Medication File will be keyed on patient ID, and will also include the unique drug key variable, instead of including all of the detailed information about the drug in each observation of the Patient Medication File. One method to get all of the detailed information about the drug into each patient drug record in the Patient Medication File would be to SORT/MERGE both files using the drug key variable. This method of adding detailed drug information to each patient drug record will be slow and inefficient, especially if the Drug Reference File has hundreds of thousands of observations, and the Patient Medication File has hundreds of millions of observations. 3
4 EMR Programming Tip Efficiently using the Drug Reference File, continued The method described by Eason (NESUG 2005) describes how to use PROC FORMAT as a speedy alternative to the SORT/MERGE. The SAS code that will create a variable for drug name, based on a format generated from the unique medication key, would look something like this: /****************************************************************/ /* Create a format for drug name from the Drug Reference File /****************************************************************/ data drgfmt (keep = start label fmtname); set in.drug_reference_file; length label $ 30; start = medication_key; /* */ /* Format for name of drug /* */ label = drug_name; fmtname = "drgfmt"; run; proc format cntlin=drgfmt library=library; run; /**********************************************************************/ /* Create a new variable in Patient Medication file using the format /**********************************************************************/ data new_drug_file; set in.patient_medication_file; length drug_name $ 30; label drug_name = "Drug Name"; drug_name = put(medication_key, drgfmt.); run; Other formats can be made that translate the unique medication key into drug strength, formulation, or any other type of information about the drug found in the Drug Reference File. OUTPATIENT ONCOLOGY EMR The drug prescription data in the outpatient oncology EMR are complicated, both in terms of the structure of the EMR data and in the actual drug treatment patterns. These EMR data describe complex chemotherapy regimens used to treat cancer patients, where each chemotherapy regimen might consist of multiple chemotherapy agents administered with different timings, supportive care for the adverse side effects of chemotherapy, and palliative care for the symptoms of cancer. These complex chemotherapy dosing schedules can be disrupted for a variety of reasons, such as patient health, adverse side effects of treatment and changes in treatment strategy. The prescription drug data in the outpatient oncology EMR have undergone little to no standardization prior to receipt of the data. This lack of standardization is especially notable for the text variables supplying the names of the chemotherapy regimens, and the names of the individual chemotherapy agents. The regimen and chemotherapy agent names are found in the EMR as trade names, brand names, and abbreviations, all of which can have alternate spellings and contain extraneous text. The outpatient oncology EMR only contains information about drugs prescribed by the outpatient oncology clinic for the treatment and care of cancer patients. The EMR does not contain prescription drug information for other types of drugs used to treat other common non-cancer conditions, such as diabetes or hyperlipidemia. The important drug data files and selected variables found in these files from in the outpatient oncology EMR are described below. 4
5 EMR File Description Selected Variables Outpatient Oncology EMR Treatment Regimen File One observation for each prescribed regimen per patient, although this file is not used by all facilities entering data into the EMR Patient Prescription File One observation for each individual agent prescribed for the patient Patient Drug Administration File One observation for each prescribed drug administered medically at the outpatient oncology clinic Regimen Key Unique treatment regimen identifier Name of the treatment regimen, unstandardized Number of cycles within each treatment plan Length of each treatment cycle Regimen start date Regimen Key Unique treatment regimen identifier if prescription is part of a defined regimen Prescription Key Unique prescription identifier Name of prescribed agent Date of prescription Over 20 separate variables used to describe the drug s prescribed dose, strength, route, frequency, duration, quantity dispensed, number of refills Prescription Key Unique prescription identifier Name of administered agent, (unstandardized text) Date of administration Variables for amount of administered dose, route of administration, and number of doses administered EMR Programming Tip Multiple inconsistently used variables for drug dose, strength, and frequency The best way to interpret variables that quantify drug dose, especially when the variables are not used consistently, is to carefully look at frequencies and cross-frequencies of all drug dosing variables prior to analysis. The variables actual values cannot automatically be assumed to be consistent with the variables definitions. For example, sometimes three separate variables will be used to indicate 2 pills (dose) of 50 mg each (strength) taken 4 times a day (frequency), calculating a total daily dose of 400 mg. Other times, the value 400 will be entered directly in the drug dose field, and the values for strength and frequency will be missing. EMR Programming Tip Standardizing Drug Names We maintain an Excel spreadsheet for almost 250 anti-neoplastic agents relevant to EMR oncology analyses. This spreadsheet gives a standardized name and classification for each anti-neoplastic agent, along with a variety of brand names, generic names, and alternate spellings that might be found as text data in the EMR. This spreadsheet is updated as needed, and converted into a SAS data set. One SAS program uses this SAS data set of standardized agent names as input to dynamically generate another SAS text standardization program. None of the actual agent names are ever hard-coded in this dynamically generated standardization program. The text standardization program also incorporates base SAS string functions, fuzzy text comparison functions, and PERL regular expression (PRX) functions as part of the text standardization process. 5
6 PRESCRIPTION TERMINOLOGY Doctors write prescriptions using abbreviations called sig codes to describe how the prescribed drug should be administered to the patient. These sig codes often contain abbreviations of Latin words that indicate when and how these drugs should be administered. Sig prescription codes can appear in an EMR as text data, which will need to be parsed out of the text data into relevant numeric variables for quantitative dose calculations. A partial list of sig codes that might be found in EMR data, and their definitions, are given in the table below: TYPE OF RX SIG CODE CODE DEFINITION Amount to take T1 Take one T2 Take two Route of drug administration PO By mouth (orally) SL Sublingual (under tongue) s.c. Subcutaneously (inject under skin) IV Intravenously (inject or infuse into veins) top Topically PR Rectally When to take drug qd Every day bid Twice a day tid Three times a day qid Four times a day qhs Once a day before bedtime q4h Every 4 hours q8h Every 8 hours qw Every week tiw Three times a week qam Every morning prn As needed The following gives an example of SAS code used to translate an EMR text variable that contains either a sig code, or the text definition of the code, into a numeric variable equal to the number of doses administered per day. The variables in the code include: ADMN_DOSE_FRQ_DESC A text variable that contains either a sig code or the text of the definition of a sig code ADMN_FRQ_X A numeric variable that quantifies every when ADMN_DOSE_FRQ_DESC = q ADMN_FRQ_UNIT A coded numeric variable that gives the units associated with ADMN_FRQ_X, where 4 = Days, 3 = Hours ADMN_DOSE_FRQ_NUM A derived numeric variable that gives the number of doses taken per day 6
7 data DRUG_daily_freq; set DRUG_orders; label admn_dose_frq_num = "Numeric daily dose frequency"; /* */ /* Translate character Dose Frequency (ADMN_DOSE_FRQ_DESC) into a number /* Need to also use variables ADMN_FRQ_X and ADMN_FRQ_UNIT when /* Dose Frequency = "q" (medical term for "every") /* Need to run cross frequencies of variables ADMN_DOSE_FRQ_DESC, /* ADMN_FRQ_X, and ADMN_FRQ_UNIT prior to writing program to make sure /* all values of unstandardized text strings found in data will be /* included in the program. /* */ if admn_dose_frq_desc = "at bedtime" then admn_dose_frq_num = 1; else if admn_dose_frq_desc = "b.i.d." then admn_dose_frq_num = 2; else if admn_dose_frq_desc = "four times a day" then admn_dose_frq_num = 4; else if admn_dose_frq_desc = "t.i.d." then admn_dose_frq_num = 3; else if admn_dose_frq_desc = "daily" then admn_dose_frq_num = 1; else if admn_dose_frq_desc = "ac am" then admn_dose_frq_num = 1; else if admn_dose_frq_desc = "pc (bid)" then admn_dose_frq_num = 2; else if admn_dose_frq_desc = "6x/d" then admn_dose_frq_num = 6; else if admn_dose_frq_desc = "q" then do; /* */ /* Units = "every day" /* */ if admn_frq_x = 1 and admn_frq_unit = 4 then admn_dose_frq_num = 1; else if admn_frq_x=3 and admn_frq_unit=4 then admn_dose_frq_num = 1/3; /* */ /* Units = "every hour" /* */ else if admn_frq_x=12 and admn_frq_unit=3 then admn_dose_frq_num = 2; end; run; TYPES OF ANALYSES WITH EMR DRUG PRESCRIPTION DATA Types of analyses that can be conducted with EMR drug prescription data include determining drug treatment patterns, identifying drug dose modifications, and quantifying total drug dose or average daily drug dose. EMR drug prescription data can also be used to quantify each patient s time to an event associated with drug treatment, such as the time to a drug discontinuation, drug switch, or modification of drug dose. DRUG TREATMENT PATTERNS EMR drug prescription data can be analyzed to determine if a patient continued drug therapy over a period of time, discontinued drug therapy, switched to use of a different drug, or added an additional drug to a treatment regimen. Each analysis of EMR drug prescription data will need to define the specific details of the rules used to characterize drug treatment patterns. Continuation of drug therapy can be determined by looking at the number of days between the end of the previous prescription and the start of the next prescription for the same drug. If an allowable number of gap days between prescriptions is defined, then patients can be considered as having continued drug use, even though the actual prescription start and stop dates might not be continuous. When the number of days between drug prescriptions exceeds the allowable number of gap days, or if a patient has been followed-up for more than the specified number of gap days without a new prescription, then that patient can be assumed to have discontinued use of the drug. 7
8 EMR Programming Tip Determining drug treatment patterns with gaps between prescriptions Set up the allowable number of gap days between prescriptions as a macro variable, instead of hard-coding the number of allowable gap days. Sensitivity analyses, based on changing the number of allowable gap days can be done more easily if the number of allowable gap days is stored in a macro variable. Switching a drug can be defined as discontinuing treatment with one drug and starting treatment with a different drug. Adding another drug can be defined as starting treatment with another drug while continuing treatment with the original drug. RELATIVE CHANGE IN DRUG DOSE Patients might need to change the prescribed dose of a drug in response to an adverse side effect, or in response to a treatment effect. Changes in drug dose can be identified by looking at the individual components of a drug prescription amount taken, frequency of administration, and dose associated with a singe dose to determine if there was a change in prescription drug dose. QUANTIFYING DRUG DOSE Total patient drug dose can be calculated several ways with EMR data, depending on the specific available prescription drug data. Daily patient drug dose can also be derived with simple computations, either by knowing the patient s daily treatment regimen, or by knowing the total amount of drug included in the prescription and the prescription s days supply. The calculation of total patient dose using real-world EMR data can require more than simple computations because a patient might have several prescriptions for a single drug. The available prescription drug data needed to derive a patient s total drug dose might be different on the different prescriptions, and any single prescription might not have sufficient data to calculate total dose for that prescription. EMR Programming Tip Calculating total drug dose from multiple prescriptions, with missing data As the number of drug prescriptions for a patient in an EMR increases, the odds are that at least one of these prescriptions will be missing some component of the relevant data needed to calculate total prescription dose. Two options for analyzing prescription drug data with missing dose variables include excluding patients with any missing drug dose data, or imputing the missing data. Imputing missing dose data can be based on data found in the patient s other prescriptions. If patients with any missing prescription data are dropped from an analysis of total dose, then the study will be biased towards patients with fewer prescriptions. CONCLUSION: As the use of EMR systems in medical practices continues to increase, the number of patients, different medical specialties represented, and total length of follow-up available on each patient will rise. As the medical and scientific communities realize the value of EMR data for health-related research, EMR systems will hopefully be designed to allow for data that are more easily accessible for analysis, especially for analysis with SAS. REFERENCES: Burt CW, Hing E, Woodwell D Electronic Medical Record Use by Office-Based Physicians: United States, 2005 Center for Disease Control, National Center for Health Statistics, Health E-Stat, July 21, Eason, Jenine, Proc Format, a Speedy Alternative to Sort/Merge, Proceedings of the 30 th Annual Sas Users Group (SUGI) Conference, Fraeman, Kathy Hardis, Dynamic Generation of SAS Data Step Programming From An Excel Data Dictionary, Proceedings of the 12 th Annual Northeast SAS Users Group (NESUG) Regional Conference,
9 Nordstrom BL, Fraeman KH, Luo W, Collins JW, O Malley CD, Nordyke RJ. Red Blood Cell Transfusions Among Cancer Patients on Chemotherapy: A Descriptive Epidemiologic Study. Journal of Clinical Oncology, 2008 ASCO Annual Meeting Proceedings Part I. Vol 26, (May 20 Supplement) 2008: Nordstrom BL, Langer C, Hussain A, Barghout V, Modi C, Lacerna L, Gralow, JR. Renal Function Among Cancer Patients with Bone Metastases Treated with Zolendronic Acid in a Real World Setting. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No 18S (June 20 Supplement) 2007: Luo W, Nordstrom B, Ranganathan G, Linz H, Stokes M, Ross SD, Knopf K. Adherence to Guidelines for use of Erythropoiesis Stimulating Agents in Patients with Chemotherapy-Induced Anemia: Trends from Electronic Medical Records. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 12 th Annual International Meeting, May , Arlington, VA. ACKNOWLEDGMENTS The author would like to acknowledge Beth L. Nordstrom, PhD, MPH, Senior Epidemiologist at the United BioSource Corporation and principal investigator for all EMR research studies in which the author participated. The author would also like to thank Dr. Nordstrom for her insightful comments while editing this manuscript. SAS is a Registered Trademark of the SAS Institute, Inc. of Cary, North Carolina. CONTACT INFORMATION Please contact the author with any comments or questions: Kathy H. Fraeman United BioSource Corporation 7101 Wisconsin Avenue, Suite 600 Bethesda, MD (240) voice (301) fax kathy.fraeman@unitedbiosource.com 9
Healthcare Math: Calculating Dosage
Healthcare Math: Calculating Dosage Industry: Healthcare Content Area: Mathematics Core Topics: Applying medical abbreviations to math problems, using formulas, solving algebraic equations Objective: Students
More informationD( desired ) Q( quantity) X ( amount ) H( have)
Name: 3 (Pickar) Drug Dosage Calculations Chapter 10: Oral Dosage of Drugs Example 1 The physician orders Lasix 40 mg p.o. daily. You have Lasix in 20 mg, 40 mg, and 80 mg tablets. If you use the 20 mg
More informationMedication Management: A Family Caregiver s Guide
Family Caregiver Guide Medication Management: A Family Caregiver s Guide Types of Medications You should make sure all of your family member s doctors and the home care nurse know all the overthe-counter
More informationPHARMACEUTICAL MANAGEMENT PROCEDURES
PHARMACEUTICAL MANAGEMENT PROCEDURES THE FORMULARY The purpose of Coventry Health Care s formulary is to encourage use of the most cost-effective drugs. The formulary is necessary because the cost of prescription
More informationAll Wales Prescription Writing Standards
All Wales Prescription Writing Standards These standards should be read in conjunction with completing the All Wales Medication Chart e- learning package, available on the Learning@NHSWales internet site
More informationNew York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee
New York City Office of Labor Relations Employee Benefits Program/Municipal Labor Committee PICA PRESCRIPTION DRUG PROGRAM Self-Injectable Medications Chemotherapy Medications Questions & Answers Last
More information10/31/2014. Medication Adherence: Development of an EMR tool to monitor oral medication compliance. Conflict of Interest Disclosures.
Medication Adherence: Development of an EMR tool to monitor oral medication compliance Donna Williams, RN PHN Carol Bell, NP MSN Andrea Linder, RN MS CCRC Clinical Research Nurses Stanford University SOM
More informationUsing Electronic Medical Records Data for Health Services Research Case Study: Development and Use of Ambulatory Adverse Event Trigger Tools
Using Electronic Medical Records Data for Health Services Research Case Study: Development and Use of Ambulatory Adverse Event Trigger Tools Hillary Mull VA Boston Healthcare System Boston University School
More informationMA 2000 Pharmacology for Medical Assistants
South Central College MA 2000 Pharmacology for Medical Assistants Course Information Description Total Credits 3.00 Total Hours 64.00 Types of Instruction In this course students will learn topics essential
More informationStandardizing the measurement of drug exposure
Standardizing the measurement of drug exposure The ability to determine drug exposure in real-world clinical practice enables important insights for the optimal use of medicines and healthcare resources.
More informationOutpatient Prescription Drug Benefit
Outpatient Prescription Drug Benefit GENERAL INFORMATION This supplemental Evidence of Coverage and Disclosure Form is provided in addition to your Member Handbook and Health Plan Benefits and Coverage
More informationExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes
ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes # scored items 1. Regulations and Pharmacy Duties 35 A. Overview of technician
More informationOffice of Clinical Standards and Quality / Survey & Certification Group
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2-21-16 Baltimore, Maryland 21244-1850 Office of Clinical Standards and Quality / Survey
More informationCoventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company
Coventry Health Care of Georgia, Inc. Coventry Health and Life Insurance Company PRESCRIPTION DRUG RIDER This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health
More informationPRINCIPLES OF PHARMACOLOGY. MEDICAL ASSISTANT S ROLE History: Drug Legislation & Regulation. Education: indication, instructions, side effects
PRINCIPLES OF PHARMACOLOGY Medical Assistants At the heart of health care MEDICAL ASSISTANT S ROLE History: prescription over the counter (OTC) alcohol (ETOH), recreational, smoking, herbal remedies Education:
More informationMARY T. INC. PROGRAM POLICY MANUAL
MARY T. INC. PROGRAM POLICY MANUAL POLICY Safe Medication Assistance and SECTION: 2-2C TITLE: Administration Policy REVISED BY: Jane Strobel, RN PAGE: 1of 6 APPLIES TO: All Services Operating Under Rule
More informationTalking With Your Doctor About Multiple Myeloma: A guide to making the most of your healthcare visits
There s a lot to think about and many important decisions to make when you or someone you care for has multiple myeloma. It s important to have an ongoing conversation with your healthcare team throughout
More informationMEDITECH TRAINING MANUAL PHARMACY APPLICATION. General Information
MEDITECH PHARMACY TRAINING MANUAL ELLSWORTH COUNTY MEDICAL CENTER September 2004 MEDITECH TRAINING MANUAL PHARMACY APPLICATION General Information Meditech is a fully integrated system consisting of applications
More informationSection II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3)
Section II When you are finished with this section, you will be able to: Define medication (p 2) Describe how medications work (p 3) List the different medication effects (p5) List the ways that medications
More informationPPP 1. Continuation of a medication to ensure continuity of care
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
More informationHealth Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents
Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationUnitedHealthcare Injectable Chemotherapy Prior Authorization (PA) Program Frequently Asked Questions
UnitedHealthcare Injectable Chemotherapy Prior Authorization (PA) Program Frequently Asked Questions Q1. What members are impacted by the UnitedHealthcare Injectable Chemotherapy PA Program? A. Beginning
More informationEMR DOCUMENTATION LYNX. Instructor Script
EMR DOCUMENTATION LYNX Instructor Script Table of Contents TABLE OF CONTENTS INFORMATION SECURITY AND CONFIDENTIALITY... 4 OVERVIEW... 5 LEARNING OBJECTIVES... 5 TIPS AND TRICKS... 5 SOLUTION ICONS...
More informationMEDICATION ADMINISTRATION Policy Owner: Erica Tennessen Policy Originated by (program or department): Program Applicable Programs: All Programs
MEDICATION ADMINISTRATION Policy Owner: Erica Tennessen Policy Originated by (program or department): Program Applicable Programs: All Programs Statutory or Regulatory Citation: Minn. Stat. 245D.05 Minn.
More informationHPSJ s Cognitive Services Program 07/2015
HPSJ s Cognitive Services Program 07/2015 Pharmacy & MTM Services Growing demand for MTM services Each year, inappropriate use of medications have led to $1.5 million dollars spent on preventable, medication-related
More informationFederal Regulations For Prescribing Scheduled Controlled Substances
Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system
More informationDISPENSING OF DRUGS BY PUBLIC HEALTH REGISTERED NURSES POST TRAINING TEST
DISPENSING OF DRUGS BY PUBLIC HEALTH REGISTERED NURSES POST TRAINING TEST June 2015 Introduction This is part three of a three-step educational program approved by the North Carolina Board of Pharmacy.
More informationCompensation Plan for Pharmacy Services
Compensation Plan for Pharmacy Services Attachment A Section 1 - Definitions ABC Pharmacy Agreement means an agreement between ABC and a Community Pharmacy as described in Schedule 2.1 of the Alberta Blue
More informationClinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients
Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients Developed by the Mid Atlantic Renal Coalition and the Kidney End of Life Coalition September 2009 This project was supported,
More informationMedicines reconciliation on admission and discharge from hospital policy April 2013. WHSCT medicines reconciliation policy 1
Medicines reconciliation on admission and discharge from hospital policy April 2013 WHSCT medicines reconciliation policy 1 Policy Title Policy Reference Number Medicines reconciliation on admission and
More informationA pharmacist s guide to Pharmacy Services compensation
Alberta Blue Cross Pharmaceutical Services A pharmacist s guide to Pharmacy Services compensation 83443 (2015/12) GENERAL DESCRIPTION... 3 Details... 3 ASSESSMENT CRITERIA... 3 Assessment for a Prescription
More informationPharmacy Technician Syllabus 14152
Pharmacy Technician Syllabus 14152 Dianne Rider 43745 180 th Street Hazel, SD 57242 Instructor Home Phone (605) 628-2103 Cell Phone (605) 881-3973 Email: dianne.rider@k12.sd.us Course Description Aim:
More informationCOMPUTERIZED PROVIDER ORDER ENTRY: AD-HOC ORDERS
COMPUTERIZED PROVIDER ORDER ENTRY: AD-HOC ORDERS Find Field Enter the desired order in the Find field. You may press Enter or select the Binoculars Icon to view all existing orderables. Orderable This
More informationPRESCRIBING FOR SMOKING CESSATION. (Adapted from the Self-Limiting Conditions Independent Study Program for Manitoba Pharmacists)
PRESCRIBING FOR SMOKING CESSATION (Adapted from the Self-Limiting Conditions Independent Study Program for Manitoba Pharmacists) Acknowledgements The Self-Limiting Conditions Independent Study Program
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: infusion_therapy_in_the_home 3/1998 2/2016 2/2017 2/2016 Description of Procedure or Service Home infusion
More informationMedication Safety and Error Prevention
Medication Safety and Error Prevention 16 LEARNING OBJECTIVES By the end of this chapter, students will be able to competently: 1. Explain the process for reporting errors. 2. Explain the difference between
More informationYour Medicine: Play It Safe
Your Medicine: Play It Safe Learn more about how to take medicines safely. Use the Medicine Record Form at the back of this booklet to keep track of your medicines. Keep this guide with your medicines
More informationMedicare Part D Plan Finder instructions
Medicare Part D Plan Finder instructions You can use these instructions to help you find the lowest cost Part D plans (both stand alone and Advantage plans) for the prescription drugs that you take. You
More informationRMIP Prescription Plan FAQ's
RMIP Prescription Plan FAQ's A new U.S. Pharmacy Benefit Manager has been selected for January 1, 2015 - CVS/caremark. 1) Why is the RMIP changing to CVS/caremark? The Express Scripts contract ends on
More informationHow Can We Get the Best Medication History?
How Can We Get the Best Medication History? Stephen Shalansky, Pharm.D., FCSHP Pharmacy Department, St. Paul s Hospital Faculty of Pharmaceutical Sciences, UBC How Are We Doing Now? Completeness of Medication
More informationMethods for Measuring Dose Escalation in TNF Antagonists for Rheumatoid Arthritis Patients Treated in Routine Clinical Practice
Methods for Measuring Dose Escalation in TNF Antagonists for Rheumatoid Arthritis Patients Treated in Routine Clinical Practice Gu NY 1, Huang XY 2, Globe D 2, Fox KM 3 1 University of Southern California,
More informationResearch funding was provided by TAP Pharmaceutical Products, Inc.
DOES THE DOSING FREQUENCY OF PROTON PUMP INHIBITORS (PPIs) AFFECT SUBSEQUENT RESOURCE UTILIZATION AND COSTS AMONG PATIENTS DIAGNOSED WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)? Boulanger L 1, Mody R 2,
More informationSECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions
SECTION N: MEDICATIONS Intent: The intent of the items in this section is to record the number of days, during the last 7 days (or since admission/reentry if less than 7 days) that any type of injection,
More informationElectronic Medical Record (EMR) Safety Results of CAH Testing. Tom Johns, PharmD Shands at the University of Florida
Electronic Medical Record (EMR) Safety Results of CAH Testing Tom Johns, PharmD Shands at the University of Florida Vendors Evaluated CPSI Healthland Cerner Test Patients Test Patient A Age: 76 y/o Sex:
More informationSPECIFICATION FINAL. Electronic Medical Records. Appendix D Reporting of Diabetes Data Requirements. OntarioMD Inc.
OntarioMD Inc. Electronic Medical Records SPECIFICATION Appendix D Reporting of Diabetes Data Requirements FINAL Date: January 17, 2011 Version: 4.0 2007-2011 OntarioMD Inc. All rights reserved TABLE OF
More informationCPOE Medication Order Entry
Ordering Specific Medications Any medication can be ordered individually. These can be searched by either the brand or generic name. NOTE: The search field setting of either starts with or contains can
More informationMESSA Saver Rx PRESCRIPTION DRUG RIDER BOOKLET. Good Health. Good Business. Great Schools.
MESSA Saver Rx PRESCRIPTION DRUG RIDER BOOKLET Good Health. Good Business. Great Schools. MESSA Saver Rx Prescription Drug Program The MESSA Saver Rx Prescription Drug Program is made available by a Group
More informationSelf-Assessment Questions
Self-Assessment Questions 1. According to the Manual, functions that technicians are generally allowed to perform include: a. Receive oral prescriptions from prescribers. b Tell patients how to use their
More informationAssistance. Teaching Plan. With Self-Administered Medication
Assistance With Self-Administered Medication Teaching Plan Note to leader: Complete Page 4 of the learning guide and insert it in the learning guide before making copies of the lesson for each learner.
More informationThe Electronic Medical Record (EMR)
Journal of Applied Medical Sciences, vol. 2, no. 2, 2013, 79-85 ISSN: 2241-2328 (print version), 2241-2336 (online) Scienpress Ltd, 2013 The Electronic Medical Record (EMR) PeterChris Okpala 1 Abstract
More informationHealth Professions Act BYLAWS SCHEDULE F. PART 2 Hospital Pharmacy Standards of Practice. Table of Contents
Health Professions Act BYLAWS SCHEDULE F PART 2 Hospital Pharmacy Standards of Practice Table of Contents 1. Application 2. Definitions 3. Drug Distribution 4. Drug Label 5. Returned Drugs 6. Drug Transfer
More informationInpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
More informationRoadmap for Medicare Navigating Medicare Part D. A guide for seniors and caregivers
Roadmap for Medicare Navigating Medicare Part D A guide for seniors and caregivers Roadmap for Medicare: Getting Oriented This Guide offers information and advice for choosing a Medicare Part D prescription
More informationElectronic Medical Record Use and the Quality of Care in Physician Offices
Electronic Medical Record Use and the Quality of Care in Physician Offices National Conference on Health Statistics August 17, 2010 Chun-Ju (Janey) Hsiao, Ph.D, M.H.S. Jill A. Marsteller, Ph.D, M.P.P.
More informationRetiree Health Care Plan Benefits 2012 Enrollment Guide. Medical Coverage: Pre-Medicare Retirees
Retiree Health Care Plan Benefits 2012 Enrollment Guide Medical Coverage: Pre-Medicare Retirees You ll choose from four medical plans: Basic, Comprehensive, Health Reimbursement Arrangement (HRA) and Health
More informationRIDER ADDING PRESCRIPTION DRUG COVERAGE
Group Health Incorporated (hereinafter referred to as GHI ) 441 Ninth Avenue New York, NY 10001 RIDER ADDING PRESCRIPTION DRUG COVERAGE RETAIL DRUG PROGRAM Deductible: Generic Drugs: Brand Name Preferred
More informationEDUCATOR S LESSON PLAN
EDUCATOR S LESSON PLAN Pharmacy Technician Training Program Student Version Orientation Orientation introduces the student to basic terms and definitions. An introduction to the Pharmacy Technician Certification
More information18% Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management. Introduction. Role of the Pharmacist
Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management Benjamin Link, PharmD, RPh Introduction According to information from the National Council on Compensation Insurance
More informationBristol-Myers Squibb Access Support Program. What Medications does the BMS Access Support Program help with? Program Registration Steps
Oncology Reimbursement Support Phone: 1-800-861-0048 Fax: 1-888-776-2370 Bristol-Myers Squibb Access Support Program The Bristol-Myers Squibb Access Support Program is designed to help patients with reimbursement
More informationEMBRYONIC DEVELOPMENT DATA ACCESS TO ACTIONABLE DATA PGD / PGS DATA OUR PROPRIETARY DATA ASSETS INCLUDE: EMR DATA CYCLE DATA
PRACTICEHWY INTEGRATES REPRODUCTIVE MEDICINE EXPERTISE AND BUSINESS INSIGHT TO PROVIDE REAL-WORLD, EVIDENCE-BASED MARKET INTELLIGENCE FOR MANAGING YOUR PRODUCT S LIFECYCLE. Access to our comprehensive
More informationGUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION
GUIDELINES GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION Preamble The purpose of this document is to provide guidance for the pharmacist
More informationMedication Utilization. Understanding Potential Medication Problems of the Elderly
Medication Utilization Understanding Potential Medication Problems of the Elderly NICE - National Initiative for the Care of the Elderly WHAT ARE MEDICATION UTILIZATION PROBLEMS AMONG THE ELDERLY? A useful
More informationPain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to
Pain Management Regulations Affect More Than Pain Management Specialists January 2012 LINDA A. KEEN MSN, JD, LHCRM LAW OFFICE OF LINDA A. KEEN P.A. TALLAHASSEE, FL Of counsel to Pain Management Regulations
More informationMedicare Part D Plan Finder instructions
Medicare Part D Plan Finder instructions These instructions may help you find the lowest cost Part D coverage (in both stand alone and Advantage plans). You may need these detailed instructions to get
More informationCANCER TREATMENT: Chemotherapy
CANCER TREATMENT: Chemotherapy Chemotherapy, often called chemo, is the use of drugs to treat a disease. The term chemotherapy is now most often used to describe a type of cancer treatment. Dr. Khuri:
More informationClinical Environment:
Medicos Consultants Structured Product Labeling (SPL) in the Clinical Environment: Electronic Health Records (EHR) & Digital Medical References (DMR) September 21, 2010 All Rights Reserved. 2010 No part
More informationCNA and NSO Risk Control Self-assessment Checklist for Nurse Practitioners 1. Self-assessment topic Yes No Actions needed to reduce risks
Risk Control Self-assessment Checklist for Nurse Practitioners This checklist is designed to help nurse practitioners evaluate risk exposures associated with their current practice. For additional nurse
More informationWHEREAS updates are required to the Compensation Plan for Pharmacy Services;
M.O. 23/2014 WHEREAS the Minister of Health is authorized pursuant to section 16 of the Regional Health Authorities Act to provide or arrange for the provision of health services in any area of Alberta
More informationW E L C O M E. Event or Meeting Title. Jiajie Zhang, PhD 2013 WISH Closing Keynote
W E L C O M E Event or Meeting Title Jiajie Zhang, PhD 2013 WISH Closing Keynote EHR Usability: The Emotional Stages Some time in the past We are here Some time in the future http://cabarettheatreblog.files.wordpr
More informationSummary ID# 13614. Clinical Study Summary: Study F3Z-JE-PV06
CT Registry ID# Page 1 Summary ID# 13614 Clinical Study Summary: Study F3Z-JE-PV06 INSIGHTS; INSulin-changing study Intending to Gain patients insights into insulin treatment with patient-reported Health
More informationStandards of Practice for Pharmacists and Pharmacy Technicians
Standards of Practice for Pharmacists and Pharmacy Technicians Introduction These standards are made under the authority of Section 133 of the Health Professions Act. They are one component of the law
More informationOral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance
Oral Oncology Treatment Regimens and the Role of Medication Therapy Management on Patient Adherence and Compliance Oral Cancer Care Therapies: The Opportunity and The Challenge Chemotherapy used to treat
More informationPrior Authorization, Pharmacy and Health Case Management Information. Prior Authorization. Pharmacy Information. Health Case Management
Prior Authorization, Pharmacy and Health Case Management Information The purpose of this information sheet is to provide you with details on how Great-West Life will be assessing and managing your claim
More informationAnnual Notice of Changes for 2014
Advocare Spirit Rx (HMO-POS) offered by Security Health Plan of Wisconsin, Inc. Annual Notice of Changes for 2014 You are currently enrolled as a member of Advocare Spirit Rx (HMO-POS). Next year there
More informationIncreasing Patient Access through Oral Parity Legislation
Increasing Patient Access through Oral Parity Legislation The Leukemia & Lymphoma Society A powerhouse among nonprofits searching for cancer cures Our Mission; Cure leukemia, lymphoma, Hodgkin s disease
More informationActive centers: 2. Number of patients/subjects: Planned: 20 Randomized: Treated: 20 Evaluated: Efficacy: 13 Safety: 20
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationAn Evaluation of Specialty Drug Pricing Under the Pharmacy and Medical Benefit
An Evaluation of Specialty Drug Pricing Under the Pharmacy and Medical Benefit March 2014 PREPARED BY Brenda Motheral, MBA, PhD President Corey Belken, PharmD Vice President Artemetrx Specialty Drug Solutions
More informationdrug trend and therapy class review CuraScript Specialty Pharmacy Management Guide & Trend Report
drug trend and therapy class review CuraScript Specialty Pharmacy Management Guide & Trend Report Drug Trend and Therapy Class Review The growth of specialty drugs continues to outpace the traditional
More informationAbacus Rx, Inc. 8000 SW 117 Ave PH-G Visit us at Miami, FL 33183 (305) 220-0400 Fax (305) 220-4900
Abacus Rx, Inc. 8000 SW 117 Ave PH-G Visit us at Miami, FL 33183 (305) 220-0400 Fax (305) 220-4900 www.abacusrx.com Thank you for your inquire! We are committed to provide Pharmacies with the finest technology
More informationErrors Associated with the Use of E-PrescribingE
Errors Associated with the Use of E-PrescribingE Eric Poon MD, MPH IS Director of Clinical Informatics, Associate Physician, Brigham and Women s s Hospital, Boston, MA Assistant Professor, Harvard Medical
More informationTABLE OF CONTENTS. Home Infusion Therapy Guidelines... 2
TABLE OF CONTENTS Home Infusion Therapy Guidelines... 2 Services normally considered eligible for benefits... 2 Description... 2 Pre-certification Requirements... 3 Billing Guidelines... 3 Home Infusion
More informationAnemia and chronic kidney disease
Anemia and chronic kidney disease THE KIDNEY FOUNDATION OF CANADA 1 Anemia and chronic kidney disease What is anemia? Anemia is a condition in which the red cells in the blood are at a low level. The red
More informationVisual Analytics to Enhance Personalized Healthcare Delivery
Visual Analytics to Enhance Personalized Healthcare Delivery A RENCI WHITE PAPER A data-driven approach to augment clinical decision making CONTACT INFORMATION Ketan Mane, PhD kmane@renci,org 919.445.9703
More informationHumulin R (U500) insulin: Prescribing Guidance
Leeds Humulin R (U500) insulin: Prescribing Guidance Amber Drug Level 2 We have started your patient on Humulin R (U500) insulin for the treatment of diabetic patients with marked insulin resistance requiring
More informationCurrent Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists
Current Rheumatoid Arthritis Treatment Options: Update for Managed Care and Specialty Pharmacists 1. Which of the following matches of biologic targets that contribute to rheumatoid arthritis (RA) and
More informationDrug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
More informationThe Coverage Gap in Medicare Part D. How to delay or avoid the Gap and save money with over-the-counter medications
The Coverage Gap in Medicare Part D How to delay or avoid the Gap and save money with over-the-counter medications MEDICARE PART D COVERAGE THE COVERAGE GAP Understanding the Coverage Gap in Medicare Part
More informationSOP for Screening of Adult Chemotherapy Electronic Prescriptions
SOP for Screening of Adult Chemotherapy Electronic Prescriptions Contents The following steps should be followed in screening a chemotherapy prescription on ARIA: 1. Patient details 2 2. Patient medical
More informationOverview of the BCBSRI Prescription Management Program
Definitions Overview of the BCBSRI Prescription Management Program DISPENSING GUIDELINES mean: the prescription order or refill must be limited to the quantities authorized by your doctor not to exceed
More informationGENERAL INFORMATION. With Express Scripts, you have access to:
CONTENTS GENERAL INFORMATION... 1 PREFERRED DRUG LIST....2 PHARMACIES... 3 PRESCRIPTIONS... 4 GENERIC AND PREFERRED DRUGS... 5 EXPRESS SCRIPTS WEBSITE AND MOBILE APP... 5 SPECIALTY MEDICATIONS... 6 PRIOR
More informationHealth Care System. Troyen Brennan, M.D., M.P.H. Executive Vice President & Chief Medical Officer
Creating a More Connected Health Care System Troyen Brennan, M.D., M.P.H. Executive Vice President & Chief Medical Officer Agenda Our Role in the Changing Health Care System CVS/minuteclinic: Growth and
More informationMeasure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety
Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
More informationMedicare Resource Guide
Medicare Resource Guide Patient Name Dear Patient, Please take the time to read the following sections of this brochure as noted by your healthcare provider. These different components of Medicare deal
More informationTHE TERMS AND CONCEPTS
Calculating Medication Compliance, Adherence, and Persistence in Administrative Pharmacy Claims Databases R. Scott Leslie, MedImpact Healthcare Systems, Inc., San Diego, CA ABSTRACT Compliance, adherence,
More informationGen. 253] 253 HEALTH OCCUPATIONS. November 28, 2001
Gen. 253] 253 HEALTH OCCUPATIONS PHARMACISTS PHYSICIANS ANTITRUST COLLABORATIVE AGREEMENTS BETWEEN PHARMACISTS AND PHYSICIANS RELATING TO DRUG THERAPY November 28, 2001 Ms. LaVerne G. Naesea Executive
More informationUNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2014 October 1 st, 2014 Department Name: Department of Pharmacy Department Director: Steve Rough, MS,
More informationCONGESTIVE HEART FAILURE PATIENT TEACHING
CONGESTIVE HEART FAILURE PATIENT TEACHING What is Heart Failure? Congestive Heart Failure occurs when the heart loses its ability to pump enough blood to meet the body s needs. Because the heart is not
More informationElectronic Medication Administration Record (emar) (For Cerner Sites Only)
POLICY NO. 1009 Approved: 12/05 Effective: 12/05 Reviewed: 9/10; 5/12 1. Purpose: Electronic Medication Administration Record (emar) (For Cerner Sites Only) To provide direction for the transcription and
More informationROLE OF THE PARENT/LEGAL GUARDIAN IN THE ADMINISTRATION OF MEDICATION AT SCHOOL
ROLE OF THE PARENT/LEGAL GUARDIAN IN THE ADMINISTRATION OF MEDICATION AT SCHOOL The parent/legal guardian who wishes medication to be administered at school to his/her child has the following responsibilities:
More information